Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3065774 | Journal of Neuroimmunology | 2007 | 10 Pages |
Abstract
We provide molecular evidence that the transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) is a negative regulator of brain EC inflammation. The PPARγ agonist pioglitazone reduces transendothelial migration of encephalitogenic T cells across TNFα-stimulated brain EC. This effect is clearly PPARγ mediated, as lentiviral PPARγ overexpression in brain EC results in selective abrogation of inflammation-induced ICAM-1 and VCAM-1 upregulation and subsequent adhesion and transmigration of T cells. We therefore propose that PPARγ in brain EC may be exploited to target detrimental EC-T cell interactions under inflammatory conditions.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Luisa Klotz, Linda Diehl, Indra Dani, Harald Neumann, Nanette von Oppen, Andreas Dolf, Elmar Endl, Thomas Klockgether, Britta Engelhardt, Percy Knolle,